Khyati Shah, PhD

TitlePostdoctoral Scholar
InstitutionUniversity of California San Francisco
Address1450 Third St
San Francisco CA 94158
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Hu HM, Zhao X, Kaushik S, Robillard L, Barthelet A, Lin KK, Shah K, Simmons AD, Raponi M, Harding TC, Bandyopadhyay S. A Quantitative Chemotherapy Genetic Interaction Map Reveals Factors Associated with PARP Inhibitor Resistance. Cell Rep. 2018 Apr 17; 23(3):918-929. PMID: 29669295.
      View in: PubMed
    2. Shah K, Wilson EA, Malla R, Elford HL, Faridi JS. Targeting Ribonucleotide Reductase M2 and NF-?B Activation with Didox to Circumvent Tamoxifen Resistance in Breast Cancer. Mol Cancer Ther. 2015 Nov; 14(11):2411-21. PMID: 26333382.
      View in: PubMed
    3. Shah K, Mehta KR, Peterson D, Evangelista M, Livesey JC, Faridi JS. AKT-induced tamoxifen resistance is overturned by RRM2 inhibition. Mol Cancer Res. 2014 Mar; 12(3):394-407. PMID: 24362250.
      View in: PubMed
    4. KN Shah, JS Faridi.Voyagers and their aids: The role of interactions between tumor and endothelial cells in brain metastasis. 2012.
    5. Shah K, Faridi JS. Estrogen, tamoxifen, and Akt modulate expression of putative housekeeping genes in breast cancer cells. J Steroid Biochem Mol Biol. 2011 Jul; 125(3-5):219-25. PMID: 21420492.
      View in: PubMed
    6. Khyati Niral Shah and Jesika S. Faridi.Estrogen, tamoxifen, and Akt modulate expression of putative housekeeping genes in breast cancer cells.
    7. Khyati N. Shah, Howard L. Elford, and Jesika S. Faridi.The ribonucleotide reductase inhibitor Didox reverses tamoxifen resistance in breast cancer cells.
    8. Shah K, and Evangelista, M .Mutations in IDH1 enhances sensitivity to LDHA inhibitors, Genentech.
    9. Shah K, Faridi JS.Identification of altered genes in tamoxifen resistant breast cancer.
    10. Shah K, Peterson D, Kowanetz K, and Evangelista M.Mapping out the "altered" metabolic network in pancreatic cancer by integration of methylation profiling and RNA-seq Genentech Inc.
    11. Khyati Niral Shah, David Peterson, Marie Evangelista, and Jesika Faridi.RRM2: a key contributor in tamoxifen resistance in breast cancer.
    Khyati's Networks
    Derived automatically from this person's publications.
    People in Profiles who have published with this person.
    Related Authors
    People who share related concepts with this person.